To solve these problems, in our research we successfully designed and prepared a novel cancer cell vaccine that can simultaneously secret anti-PD-1 mAbs and GM-CSF locally and might allow higher concentrations at the tumor area while reducing systemic side effects. Here, CSF2 is linked to cancer.